Introduction
============

Cervical disc arthroplasty (CDA) was first published in the medical literature by Reitz and Joubert \[[@b1-asj-2018-0008]\] in the South African Medical Journal in 1964. Since its introduction, the use of CDA for treating symptomatic cervical disc pathology has continued to increase. This has been supported by favorable outcomes reported in the literature \[[@b2-asj-2018-0008]-[@b6-asj-2018-0008]\]. Its use has also been facilitated by the theoretical benefit to the adjacent levels with maintained disc motion \[[@b7-asj-2018-0008],[@b8-asj-2018-0008]\]. However, an increased use of CDA has identified potential complications \[[@b9-asj-2018-0008],[@b10-asj-2018-0008]\], including those associated with the surgical approach (infections, neurovascular injury, and dysphagia), surgical technique (wrong level surgery, persistent neurological deficit, postoperative kyphosis, migration, and subsidence), and implant (failure, debris, heterotrophic ossification, osteolysis, and dislocation) \[[@b9-asj-2018-0008]\].

Multiple implants are available for use in CDA, including those with various materials, biomechanical philosophies, and constraint degrees. However, all implants aim to maintain motion and thus, like other joint arthroplasties, are prone to bone loss from debris deposition, micromotion, and stress shielding \[[@b11-asj-2018-0008]-[@b23-asj-2018-0008]\].

Anterior bone loss (ABL) in CDA has been recognized in ProDisc \[[@b24-asj-2018-0008],[@b25-asj-2018-0008]\], Bryan CDA \[[@b22-asj-2018-0008]\], and Baguera-C CDA implants \[[@b26-asj-2018-0008]\]. In ProDisc, bone loss was observed around its central keel \[[@b24-asj-2018-0008],[@b25-asj-2018-0008]\]. In contrast, in Bryan CDA bone loss predominantly affects the superior adjacent vertebra of the operative segment around the anterior flange of the prosthesis \[[@b22-asj-2018-0008]\]. Heo et al. \[[@b26-asj-2018-0008]\] reported on 48 patients treated with Baguera-C CDA and showed that ABL occurred in more than 60% of the patients.

We hypothesized that ABL in CDA is rare and progressive. This study therefore aimed to examine the radiographic sequential progression of ABL and to understand its natural history to predict the likely etiology and provide surgeons with an understanding of this phenomenon.

Materials and Methods
=====================

We performed a retrospective analysis of longitudinal observations using standardized of antero-posterior (AP), lateral and flexion/extension radiographs of non-keeled CDAs performed within L'Institut de la Colonne Vertébrale, CHU Pellegrin, Bordeaux, France with a minimum 5-year follow-up. The implants included the Bryan disc (Medtronic Sofamor Danek, Memphis, TN, USA; 46 patients), the Discocerv (Alphatech Spine Inc., Carlsbad, CA, USA; 41 patients), and the Baguera C (Spineart, Geneva, Switzerland; 59 patients).

This study was approved by the Institutional Review Board of L'Institut de la Colonne Vertébrale, CHU Pellegrin, Bordeaux, France (IRB approval no., IRB01ABL).

Images were assessed by DK and confirmed by DC. ABL was recorded as the percentage AP subchondral vertebral body length, referenced from the posterior vertebral body line, at follow-up compared with that in the immediate postoperative lateral X-ray ([Fig. 1](#f1-asj-2018-0008){ref-type="fig"}).

Implant uncoverage was defined as more than 2 mm of anterior implant exposure or endplate collapse and implant subsidence was defined as more than 5° of kyphotic change in the implant position relative to the posterior vertebral line or more than 2 mm of height loss of the implant relative to the anterior or posterior vertebral body height of the immediate postoperative X-ray ([Fig. 2](#f2-asj-2018-0008){ref-type="fig"}).

Each endplate was analyzed in isolation, such that each implant had two endplates assessed (upper being cranial and lower being caudal of the implant). Endplates that were not clearly visible were excluded. To ensure that no markedly malpositioned implants were studied, endplates that had implants that were positioned more anteriorly than 3 mm from the posterior vertebral line on the lateral X-ray or had more than 3 mm of central asymmetry on the AP X-ray (defined as the distance from the midpoint of the implant compared to the midpoint of the superior endplate) were excluded. Comparative radiographs were studied at 6 weeks, 3, 6, 9, 12, 18, and 24 months, and annually thereafter, with a minimum follow-up of 5 years (maximum, 8 years). For each time interval, ABL was assessed. If the patient failed to have a radiograph taken at the intended time interval, the ABL for that time interval was not recorded, unless there was no difference between the previous and subsequent radiographs, in which case the ABL was recorded as the same amount as in the adjacent time periods.

ABL was classified into three groups: mild (≤5%), moderate (6%--10%), and severe (\>10%). The radiographic natural history was studied. In addition, Visual Analog Scale (VAS) neck and arm pain scores were obtained preoperatively, 3 months postoperatively, and 5 years postoperatively. Neck Disability Index (NDI) scores were obtained at 5 years. Pain and functional outcome scores were compared among the groups.

Statistical results are presented as mean values (and/or percentages) with standard deviations. Chi-square test of independence was used to identify relationships of age (5-year age brackets), sex, or operated level with ABL degree. At each observation period, the VAS and NDI results were compared among the different ABL-degree groups, using one-way analysis of variance. Where these analyses indicated significant associations, pairwise comparisons among the ABL groups were undertaken. Statistical significance was defined as a two-tailed p-value of less than 0.05.

Results
=======

Of the 146 patients that were analyzed, complete radiological assessment was available for 114 patients and 156 CDAs (average age, 45.3 years; maximum, 65 years; minimum, 28 years; 57% females). This comprised 56 with Bryan (Medtronic Sofamor Danek, 32 patients), 44 with Discocerv (Alphatech Spine Inc., 38 patients), and 56 with Baguera-C CDAs (Spineart, 44 patients). Of these, 78 patients had single-level, 30 had double-level, and six had triple-level CDAs. Thirteen patients had a hybrid procedure with concomitant fusion at the time of CDA. In all cases, the posterior longitudinal ligament was resected, whereas the uncinate processes were not.

From the 156 CDAs, 309 endplates were assessed, including 55 upper and 56 lower Bryan (Medtronic Sofamor Danek), 44 upper and 44 lower Discocerv (Alphatech Spine Inc.), and 54 upper and 56 lower Baguera-C (Spineart) CDAs. The most common level operated on was C5/6 (range, C3/4--C6/7).

ABL was identified in 57.1% of CDAs ([Table 1](#t1-asj-2018-0008){ref-type="table"}) and had no identified correlation with age, sex, or operated level (*p*\>0.05). Severe ABL was only identified in the Discocerv CDA (11.4% of Discocerv CDAs, Alphatech Spine Inc.) and included one single-level, double-level, and triple-level CDA each. Of the 309 endplates assessed, 48.5% were affected by ABL ([Table 2](#t2-asj-2018-0008){ref-type="table"}).

Mild and moderate ABL predominantly affected the upper endplate (56.8% and 57.9%, respectively). Severe ABL predominantly affected the lower endplate (66.7%), especially when endplate collapse occurred (75%).

The natural history of ABL showed that this phenomenon typically commenced within 3 months of the index operation and followed a benign course, with improvement in bone stock after the initial bone loss ([Fig. 3](#f3-asj-2018-0008){ref-type="fig"}). Throughout the study period, all implants remained stable with no implants revised or repeat operations recorded.

Most ABL identified was mild (45.5% of CDAs, 40.5% of endplates). It typically appeared as blunting of the anterior vertebra commencing within the first 3 months and the display of stable radiographic features after 6--9 months ([Fig. 4](#f4-asj-2018-0008){ref-type="fig"}). No implant subsidence or implant uncoverage occurred.

Moderate ABL was identified in 8.3% of CDAs (6.1% of endplates). It typically resulted in anterior CDA uncoverage (61.5%), but a stable radiographic appearance after 9--12 months ([Fig. 5](#f5-asj-2018-0008){ref-type="fig"}). No implant subsidence occurred.

Severe ABL was rare (3.2% of CDAs, 1.9% of endplates). It typically commenced within the first 3 months, with progression during the first year, but with stable or improving radiographic features after this period ([Fig. 5](#f5-asj-2018-0008){ref-type="fig"}).

Severe ABL always caused anterior uncoverage of the CDA and compromised endplate stability causing implant subsidence in 66.7% of cases. Endplate collapse and implant subsidence were seen to affect the anterior portion of the vertebra more than the posterior portion, even when the entire endplate was affected. However, the bone typically healed in the collapsed position to provide a stable implant with maintenance of prosthetic function or subsequent fusion ([Fig. 6](#f6-asj-2018-0008){ref-type="fig"}).

Occasionally, despite severe ABL, the implant did not subside or did so only minimally (\<20° or 4 mm). In these cases, the bone reconstituted beneath the implant over a number of years along with the maintenance of implant stability ([Fig. 6](#f6-asj-2018-0008){ref-type="fig"}).

[Table 3](#t3-asj-2018-0008){ref-type="table"} illustrates the pain and functional outcome scores according to ABL degree and follow-up duration. There was no significant association between VAS scores or NDI and ABL degree. Within the timeframe of this study, there was no evidence of progressive disease, overall, or when each category of ABL was analyzed independently.

Discussion
==========

ABL is a common condition (57.1% of CDA). Its natural history involves non-progressive early bone loss commencing within 3 months of the index operation, which favors early bone remodeling or an osteolytic insult inflicted during the procedure. Notably, the natural history is not consistent with wear debris or low-grade infection, which would more likely produce progressive bone loss.

Heo et al. \[[@b26-asj-2018-0008]\] propose that the most likely cause of this phenomenon is stress shielding from the implant. However, implant-related stress shielding occurs when a portion of the bone is no longer loaded and thus resorbs. This phenomenon, at least in large joints, progressively occurs over several years rather than the first 3 months \[[@b27-asj-2018-0008]-[@b29-asj-2018-0008]\]. Furthermore, a rebound of bone formation does not occur, as only bone that is not loaded is initially resorbed. In our series, we found early bone loss with subsequent reconstitution. This would suggest that stress shielding from the implant is unlikely. Furthermore, we included multiple implant types to ensure a diverse modulus of elasticity and biocompatibility and found this phenomenon occurring in all implant types studied. Therefore, we believe that the cause is not likely to be implant-related stress shielding.

Rather, we believe that the bone resorption occurs from resection of the anterior longitudinal ligament, which no longer tractions the anterior vertebral beak and is therefore likely to account for the ABL encountered in mild and moderate cases. An alternative cause in these cases could be a direct osteolytic insult, such as heat necrosis from cautery, inflicted on the anterior vertebra during the exposure of the intervertebral disc.

Owing to the size and rate of ABL in severe cases, we believe that the cause is more likely related to a surgical insult causing avascular necrosis (AVN) of the anterior portion of the endplate. It has been well described that the vertebral body obtains most of its vascular supply from a branch of the posterior arterial vertebral plexus that penetrates the vertebral body through the basivertebral foramen \[[@b30-asj-2018-0008]\]. However, this is not the sole supply of the vertebra. An additional vessel, commencing within the same posterior plexus, wraps around the vertebra to terminate in a small anterior nutrient artery \[[@b30-asj-2018-0008]\]. Significant anatomical variations occur and the degree of anterior vertebra supplied by this vessel is not known. However, it is likely that, in some patients, this vessel greatly contributes to the vascularity of the anterior vertebral body.

To date, the exact insult causing AVN remains unknown. Intra-operatively, a lateral vessel is often encountered and coagulated at the margin of the longus coli ([Fig. 7](#f7-asj-2018-0008){ref-type="fig"}). However, this is the vessel described above and its damage may contribute to AVN of the anterior vertebra in a patient with predominant anterior vascular supply. Similarly, midline dissection and exposure with the insertion of traction pins may directly injure the anterior nutrient artery as it penetrates the vertebra, resulting in the same effect. Alternative causes of AVN include direct endplate damage during endplate preparation or endplate hyperpressure from the implant.

We classified ABL according to the percentage of subchondral bone loss occurring relative to the level at the initial postoperative X-ray ([Fig. 1](#f1-asj-2018-0008){ref-type="fig"}). In some centers, the anterior beak is resected routinely during the surgical procedure; however, at our institution, beak resection is not performed. Thus, our classification includes regression of the beak as is seen in mild cases.

We utilized a percentage-based classification system of ABL to accurately define the extent of this phenomenon. Clearly, an anteriorly placed implant, or oversized implant, with the same ABL degree will have greater implant exposure than a more centrally positioned, adequately sized one ([Fig. 8](#f8-asj-2018-0008){ref-type="fig"}). Therefore, our classification system, which utilizes the percentage of ABL rather than the degree of implant exposure, accounts for moderate variations in the initial implant position. However, it should be recognized that our study excluded markedly malpositioned implants. Thus, it is possible that a poorly positioned implant may subside with less ABL than described in our classification system. In view of this, further analysis of the percentage of implant support necessary to prevent implant collapse is necessary.

In our proposed classification system ([Table 4](#t4-asj-2018-0008){ref-type="table"}), mild cases are described as those with ≤5% ABL and typically involve blunting of the anterior vertebral beak. This occurs more commonly than no bone loss (45.5% versus 42.9%) and does not expose or compromise the implant. The authors believe that mild ABL is of no concern and does not warrant continued monitoring.

Moderate ABL is described as ABL of 6%--10% and is similar to mild cases, but may expose the implant. However, the endplate is not compromised and the implant remains stable; thus, we believe that continued monitoring is not necessary.

Severe ABL is described as that of \>10%, is likely caused by AVN of the anterior subchondral bone, and the bone loss always extends beyond the anterior portion of the implant. This ABL degree may compromise the biomechanical integrity of the endplate and risk implant subsidence. If subchondral collapse occurs, the bone typically heals in the collapsed position and may auto-fuse. If collapse does not occur, the initial bone defect will typically reconstitute partially or completely over a number of years. We therefore advocate close monitoring in severe cases without implant collapse until radiographic improvement or a stable state is attained (usually 1 year). We are currently monitoring severe cases with implant collapse to ensure the integrity of the adjacent levels. To date, with a minimum follow-up of 5 years, we have not encountered adjacent segment disease in any of these cases.

Irrespective of the ABL degree identified, it is important to note that continued progression of ABL did not occur beyond the first year. This is consistent with the results reported by Heo et al. \[[@b26-asj-2018-0008]\]. Thus, we propose that ABL is a non-progressive phenomenon and, provided that it follows this typical natural history, the implant can be observed and the patient treated non-operatively.

In addition, the range of implants studied in this review and those reported in previous publications would suggest that ABL is not implant-specific, but rather techniquespecific \[[@b22-asj-2018-0008],[@b24-asj-2018-0008]-[@b26-asj-2018-0008]\]. We would therefore agree with previous authors who have excluded the anterior flange of the Bryan disc as the cause of ABL in this prosthesis \[[@b26-asj-2018-0008]\]. We would also advocate further research into the surgical risk factors contributing to this phenomenon.

We also found no correlation between ABL degree and 3-month VAS scores. Heo et al. \[[@b26-asj-2018-0008]\] found that, despite all patients improving from their preoperative state, similar to our patients, there were significantly lower functional scores and higher pain scores within the first year for patients with ABL causing exposure of the prosthesis. We analyzed VAS scores at 3 months because all patients with ABL had radiological evidence of this phenomenon at this time point. However, our study is limited by a lack of additional pain and functional scores during the first year.

Heo et al. \[[@b26-asj-2018-0008]\] found that the difference in early functional scores with those who develop ABL improved and that there was no difference between the groups after the first year. This is consistent with our radiographic results, which suggest that ABL occurs at an early stage and follows a non-progressive course with stable radiographic features beyond the first year. This is also supported by our 5-year VAS and NDI scores showing no significant differences between the groups.

Reassuringly, within the timeframe of this study, none of the patients required repeated surgical intervention. Thus, the clinical effect of this phenomenon remains unclear. However, clinicians can be reassured about its benign nature and mid-term results.

A limitation of this study is the analysis of only nonkeeled implants, which were specifically chosen to optimize the radiological assessment, which is otherwise obscured by an artifact from the keel. Additionally, patient's medical comorbidities did not correlate with the activity level. Similarly, the degree of surgical insult to the anterior vertebra, the use of distraction pins, and the amount of pre-vertebral coagulation were unknown. In addition, markedly malpositioned implants were not included in the study, and therefore the endplate collapse and implant subsidence rates only reflect the results in adequately positioned implants. Lastly, despite the large number of CDAs reported, the numbers of each implant type were low and precluded accurate assessment of the risk among the implants. Despite our study only illustrating severe ABL in the Discocerv CDA, our institution has managed severe ABL affecting multiple different prostheses, but these were not included in the current study due to our exclusion criteria, particularly external referrals from other centers and limited radiographic follow-up.

Owing to these limitations, our proposed causes of ABL need to be interpreted with caution. Further research is warranted to account for the shortcomings of this study. We would also encourage an assessment of ABL in anterior cervical discectomy and fusion procedures to further prove that ABL occurs due to the surgical technique used rather than it being an implant-specific phenomenon.

Conclusions
===========

This study demonstrates that ABL is a common condition (57.1%). It occurs at an early stage (within 3 months) and follows a non-progressive natural history, typically with stable radiographic features after the first year. ABL is mostly observed to be mild, but severe ABL occurs in approximately 3% of CDAs. It does not affect the patient's clinical outcome or the requirement for revision surgery. Surgeons should be aware of this phenomenon and treat patients expectantly.
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![Technique of measuring ABL. Arrowed lines represent the subchondral length; dashed line represents the posterior vertebral line. The numeric formula used to determine the percentage of ABL was: ABL=(a−b)/a×100. (A) Immediate postoperative X-ray. (B) Follow-up X-ray. ABL, anterior bone loss.](asj-2018-0008f1){#f1-asj-2018-0008}

![Illustration of the anterior implant exposure (defined as b \>2 mm) and implant subsidence (defined as either: x \>5° or a--d \>2 mm).](asj-2018-0008f2){#f2-asj-2018-0008}

![Change in the percentage of ABL over time for mild, moderate, and severe ABL groups. ABL, anterior bone loss.](asj-2018-0008f3){#f3-asj-2018-0008}

![Radiographs of the lateral cervical spine of a representative case with multi-level cervical disc arthroplasties showing the natural history of mild anterior bone loss (arrow).](asj-2018-0008f4){#f4-asj-2018-0008}

![Radiographs of the lateral cervical spine of a representative case showing the natural history of moderate ABL in the upper endplate and severe ABL with collapse in the lower endplate (arrow). ABL, anterior bone loss.](asj-2018-0008f5){#f5-asj-2018-0008}

![Severe anterior bone loss with minimal implant collapse and initial bone loss reconstitution (arrow).](asj-2018-0008f6){#f6-asj-2018-0008}

![Illustration of the anterior view of the spine with the proposed nutrient vessels of the anterior vertebrae.](asj-2018-0008f7){#f7-asj-2018-0008}

![Two cases of moderate ABL, with (A) being an adequately positioned and sized implant and (B) being a comparatively anteriorly positioned and oversized implant. Note the implant exposure in (B). However, the percentage of ABL was same for both the cases. ABL, anterior bone loss.](asj-2018-0008f8){#f8-asj-2018-0008}

###### 

Maximal degree of anterior bone loss identified per cervical disc arthroplasty

  Implant        None        Mild        Moderate   Severe     Total
  -------------- ----------- ----------- ---------- ---------- -------
  All implants   67 (42.9)   71 (45.5)   13 (8.3)   5 (3.2)    156
  Bryan          24 (42.9)   25 (44.7)   7 (12.5)   0          56
  Discocerv      23 (52.3)   12 (27.3)   4 (9.1)    5 (11.4)   44
  Baguera C      20 (35.7)   34 (60.7)   2 (3.6)    0          56

Values are presented as number (%). The implants were from the following companies: Bryan disc (Medtronic Sofamor Danek, Memphis, TN, USA), the Discocerv (Alphatech Spine Inc., Carlsbad, CA, USA), and the Baguera C (Spineart, Geneva, Switzerland).

###### 

Maximal degree of anterior bone loss per endplate

          None         Mild         Moderate   Severe    Total
  ------- ------------ ------------ ---------- --------- -------
  Upper   69 (45.1)    71 (46.4)    11 (7.2)   2 (1.3)   153
  Lower   90 (57.7)    54 (34.6)    8 (5.1)    4 (2.6)   156
  Total   159 (51.5)   125 (40.5)   19 (6.1)   6 (1.9)   309

Values are presented as number (%).

###### 

Comparative pain and functional outcome scores according to the degree of ABL (°)

  Degree of ABL (°)   VAS neck   VAS arm   Neck Disability Index                           
  ------------------- ---------- --------- ----------------------- ------- ------- ------- -------
  None                5.7        2.4       2.2                     6.2     1.7     1.6     18.9
  Mild                6.0        1.2       1.1                     7.0     1.1     1.1     11.2
  Moderate            6.2        0.8       1.7                     7.4     0.7     1.3     10.1
  Severe              5.9        3.0       2.6                     8.0     1.8     3.1     9.0
  *p*-value           0.930      0.286     0.081                   0.600   0.489   0.577   0.094

ABL, anterior bone loss; VAS, Visual Analog Scale; Preop, preoperative; Postop, postoperative.

###### 

Classification of anterior bone loss

  Grade                          Anterior bone loss (%)   Cervical disc arthroplasty (%)   Cause                                              Radiograph   Implant exposure   Endplate compromise   Treatment
  ------------------------------ ------------------------ -------------------------------- -------------------------------------------------- ------------ ------------------ --------------------- -----------
  0 (None)                       0                        42.9                             \-                                                              No                 No                    Nil
  1 (Mild)                       1--5                     45.5                             Direct anterior vertebral injury or resected ALL                No                 No                    Nil
  2 (Moderate)                   6--10                    8.3                              Direct anterior vertebral injury or resected ALL                Potential          No                    Nil
  3 (Severe with-out collapse)   \>10                     0.6                              Avascular necrosis                                              Yes                No                    Monitor
  4 (Severe with collapse)       \>10                     2.6                              Avascular necrosis                                              Yes                Yes                   Monitor

ALL, anterior longitudinal ligament.
